Submit RFI/RFP SEARCH MENU About PrimeVigilance We help emerging and established companies meet their regulatory obligations PrimeVigilance, an Ergomed Group company, was established in 2008 by Dr. Miroslav Reljanovic together with co-founder Dr. Elliot Brown. PrimeVigilance oﬀers holistic, top quality, cost-eﬀective, innovative safety services for pharmaceutical, generic and biotechnology companies. Our founders and leaders have an unrivalled reputation in the sector with a network of expert associates across the world. These include former senior regulators and consultants with extensive industry experience, especially with marketed products. Ensuring a world with safer drugs OUR MISSION We are recognised for the quality of our services and the professionalism of our team PrimeVigilance has grown organically since 2008 and we now have over 800 people working from our seven main offices in the United Kingdom, United States, Croatia, Czech Republic, Germany, Poland, Serbia and Japan. Our pharmacovigilance services cover all the regulatory and scientific elements required to obtain and maintain a product licence. PrimeVigilance also offers fully integrated international Medical Information, Pharmacoepidemiology and Benefit-Risk Management services. PrimeVigilance specialises in helping emerging companies comply with regulations, from developing the initial Detailed Description of PV Systems and RMP right through to full management of safety operations. OPERATIONAL LEADERSHIP TEAM Meet the people behind PrimeVigilance PrimeVigilance is a subsidiary of Ergomed plc. and is managed by its own Board of Directors which includes leading pharmacovigilance experts + CORPORATE SOCIAL RESPONSIBILITY Contributing toward a better world PrimeVigilance recognises that its activities and operations have a societal impact and we place a high emphasis on our social responsibilities. + “It has been a pleasure working with you, having your expertise and prompt support with our literature search activities – all much-much appreciated!” Group Medical Director, Medical Safety Review Worldwide Patient Safety (WWPS) Large worldwide Pharmaceutical company >1,500 PBRERS, PADERs, DSURs, ACOs, RMPs written per year >900,000 Literature abstracts reviewed yearly >300,000 ICSRs/SAEs processed every year >600 Signal evaluation reports prepared every year >42 PSMFs drafted of which 34 managed in-house >40,000 Medical information inquiries received per year Discover how we can help you CONTACT US Download our brochure +44 (0)1483 307920 (+1) 919-401-8003 ABOUT US Our Mission, Core Values and Vision Executive Management Team Operational Leadership Team Corporate Social Responsibility An Ergomed Group Company PHARMACOEPIDEMIOLOGY Strategic Consulting Benefit-Risk Management Services Human Data Research Services Training Systematic Literature Reviews & Meta-Analysis PHARMACOVIGILANCE Pharmacovigilance Outsourcing Support Services Outsourcing Specialist Support Outsourcing Pharmacovigilance Consulting Postmarketing Clinical trials MEDICAL INFORMATION Service Introduction Query Management Quality Management INFORMATION & RESOURCES What is Pharmacovigilance? Pharmacovigilance Information Webinars Complexities in Drug Safety Download Case Study Download PrimeVigilance brochure Download Ergomed Group brochure LOCATIONS United Kingdom (Head Office) PrimeVigilance Ltd 1 Occam Court Surrey Research Park Guildford, Surrey GU2 7HJ USA PrimeVigilance USA Inc. 100 Regency Forest Drive Suite 160 Cary NC 27518 USA Croatia PrimeVigilance Zagreb d.o.o. Oreskoviceva 20A 10020 Zagreb Germany PrimeVigilance GmbH Herriotstr. 1, 60528, Frankfurt am Main Czech Republic PrimeVigilance s.r.o. Stetkova 18 140 00 Praha 4 Serbia PrimeVigilance d.o.o. Beograd Đorđa Stanojevića 14 11070 Novi Beograd Poland PrimeVigilance – Ergomed Sp. z.o.o. Ul. Armii Krajowej 18 30-150 Krakow Japan PrimeVigilance Japan K.K. 3-1-6 Motoazabu, Minato-ku, Tokyo, Japan © PrimeVigilance 2021 An group company Sitemap Privacy policy Anti-Slavery statement Legal information